Mevalonate kinase deficiency and Dutch type periodic fever

被引:0
|
作者
Frenkel, J
Houten, SM
Waterham, HR
Wanders, RJA
Rijkers, GT
Kimpen, JLL
Duran, R
Poll-The, BT
Kuis, W
机构
[1] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Gen Pediat, NL-3508 AB Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Immunol, NL-3508 AB Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Metab Disorders, NL-3508 AB Utrecht, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Clin Chem & Pediat, NL-1105 AZ Amsterdam, Netherlands
关键词
fever; IgD; hypergammaglobulinemia; mevalonate kinase; mevalonic acid; familial Mediterranean fever; periodicity;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dutch type periodic fever (DPF) is an autosomal recessive hereditary fever syndrome. Cases have been reported worldwide, the majority from France and The Netherlands. From infancy the patients suffer fever attacks that recur every 2-8 weeks, often precipitated by immunizations, infections or emotional stress. Fever lasts 2-7 days and can be accompanied by malaise, headache diarrhea, abdominal pain vomiting, skin rashes, arthralgia, arthritis, tender lymphadenopathy: hepatosplenomegaly and oral and genital ulcers. Labarotory evaluation during fever shows granulocytosis and elevated acute phase reactants. DPF is caused by a deficiency of the enzyme mevalonate kinase (MK). Besides DPE, the spectrum of MK deficiency includes a severe phenotype, mevalonic aciduria (MA). MA patients have less residual MK activity leading to substantially higher urinary, mevalonic acid excretion than in DPF. Mevalonic aciduria is characterized by mental retardation and dysmorphic features in addition to the clinical features of DPE At the genomic level, several mutations of varying severity have been identified The DPF phenotype is caused by one particular mild missense mutation. Most patients are compound heterozygotes for this mutation and a more severe mutation. The mechanism by which MK deficiency lends to fever is not understood. The vast majority of DPF patients have persistently, elevated serum IgD and can be classified as having hyperimmunoglobulinemia D and periodic fever syndrome (HIDS). Conversely, most HIDS patients have MK deficiency and hence DPF, but the two disorders do not overlap entirely.
引用
收藏
页码:525 / 532
页数:8
相关论文
共 50 条
  • [31] Management of Mevalonate Kinase Deficiency: A Pediatric Perspective
    Jeyaratnam, Jerold
    Frenkel, Joost
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [32] Weekly oral alendronate in mevalonate kinase deficiency
    Luca Cantarini
    Antonio Vitale
    Flora Magnotti
    Orso Maria Lucherini
    Francesco Caso
    Bruno Frediani
    Mauro Galeazzi
    Donato Rigante
    Orphanet Journal of Rare Diseases, 8
  • [33] Mevalonate Kinase Deficiency: Diagnostic and Management Challenges
    Choudhary, Puneet Kumar
    Parihar, Vivek
    Satapathy, Jagatshreya
    Bagri, Narendra Kumar
    INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (09): : 937 - 938
  • [34] Molecular and cellular consequences of mevalonate kinase deficiency
    Politiek, Frouwkje A.
    Turkenburg, Marjolein
    Henneman, Linda
    Ofman, Rob
    Waterham, Hans R.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (05):
  • [35] Weekly oral alendronate in mevalonate kinase deficiency
    Cantarini, Luca
    Vitale, Antonio
    Magnotti, Flora
    Lucherini, Orso Maria
    Caso, Francesco
    Frediani, Bruno
    Galeazzi, Mauro
    Rigante, Donato
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
  • [36] Mevalonate kinase deficiency - Evidence for a phenotypic continuum
    Simon, A
    Kremer, HPH
    Wevers, RA
    Scheffer, H
    de Jong, JG
    van der Meer, JWM
    Drenth, JPH
    NEUROLOGY, 2004, 62 (06) : 994 - 997
  • [37] Mevalonate Kinase Deficiency: A Survey of 50 Patients
    Bader-Meunier, Brigitte
    Florkin, Benoit
    Sibilia, Jean
    Acquaviva, Cecile
    Hachulla, Eric
    Grateau, Gilles
    Richer, Olivier
    Farber, Claire Michele
    Fischbach, Michel
    Hentgen, Veronique
    Jego, Patrick
    Laroche, Cecile
    Neven, Benedicte
    Lequerre, Thierry
    Mathian, Alexis
    Pellier, Isabelle
    Touitou, Isabelle
    Rabier, Daniel
    Prieur, Anne-Marie
    Cuisset, Laurence
    Quartier, Pierre
    PEDIATRICS, 2011, 128 (01) : E152 - E159
  • [38] Putative modifier genes in mevalonate kinase deficiency
    Marcuzzi, Annalisa
    Vozzi, Diego
    Girardelli, Martina
    Tricarico, Paola Maura
    Knowles, Alessandra
    Crovella, Sergio
    Vuch, Josef
    Tommasini, Alberto
    Piscianz, Elisa
    Bianco, Anna Monica
    MOLECULAR MEDICINE REPORTS, 2016, 13 (04) : 3181 - 3189
  • [39] Mevalonate kinase deficiency, a metabolic autoinflammatory disease
    van der Burgh, Robert
    ter Haar, Nienke M.
    Boes, Marianne L.
    Frenkel, Joost
    CLINICAL IMMUNOLOGY, 2013, 147 (03) : 197 - 206
  • [40] CHARACTERIZATION OF IMMUNE DEFECTS IN MEVALONATE KINASE DEFICIENCY
    Piscianz, E.
    Marcuzzi, A.
    Valencic, E.
    Tommasini, A.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 64 - 65